A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

Clinical trial NCT00128479 · COMPLETED

Trial details

NCT number: NCT00128479
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder Psychotic Disorders

Start date: 2004-09-01
Primary completion: 2007-01-01
Enrollment: 443

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.